Engineering the Next Generation of Radiopharmaceutical Platforms: Lessons Learned from First-Generation RLTs

11:00 am - Tuesday 1st December 2026

  • Understanding the pharmacokinetic limitations restricting today’s radioligand therapies
  • Optimising vector design, tumour localisation and therapeutic index to improve clinical outcomes
  • Applying platform-level lessons to develop more effective next generation radiopharmaceuticals

Speakers:

President & Chief Scientific Officer
Ratio Therapeutics, Inc.